Cheyne Capital Management (UK) LLP - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 60 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 3.99 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cheyne Capital Management (UK) LLP ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2015$137,000
-53.6%
62,000
-50.8%
0.06%
-32.6%
Q2 2015$295,000
-8.1%
125,892
-16.1%
0.10%
+23.4%
Q1 2015$321,000
-5.0%
150,0000.0%0.08%
-13.5%
Q4 2014$338,000150,0000.09%
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q4 2014
NameSharesValueWeighting ↓
Steamboat Capital Partners, LLC 817,521$414,0000.37%
Abingworth LLP 396,104$195,0000.19%
BOOTHBAY FUND MANAGEMENT, LLC 60,638$31,0000.01%
EAGLE GLOBAL ADVISORS LLC 128,520$65,0000.00%
PANAGORA ASSET MANAGEMENT INC 949,438$481,0000.00%
Renaissance Technologies 908,100$460,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 46,100$23,0000.00%
DEUTSCHE BANK AG\ 5$00.00%
CITIGROUP INC 10,376$5,0000.00%
GOLDMAN SACHS GROUP INC 20,037$10,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders